Effects of diltiazem and nitroglycerin on prostaglandin F2 alpha-induced periodic contractions of isolated human coronary arteries. 1985

K Kawasaki, and K Seki, and I Miyazawa, and N Matsumoto, and N Nakanishi, and T Iino, and S Hosoda

This study characterizes the inhibiting effect of diltiazem and nitroglycerin on periodic contractions of isolated human coronary arteries. Isometric force of coronary ring segments from sixty-nine cadavers was recorded in a muscle bath. To quantify the experimental results, we used 3 X 10(-6) M prostaglandin F2 alpha to induce the periodic contractions of a certain force. When diltiazem was added during the periodic contractions, the amplitude of oscillations gradually decreased until eventually oscillations ceased completely. The process prior to the cessation of the oscillations was characterized mainly by the inhibition of the contraction phase. The inhibition rate at the time of the complete cessation of oscillations was 49.3 +/- 6.3% at 5 X 10(-7) M. The time required for complete disappearance of oscillations was dependent on the diltiazem concentration. When nitroglycerin was added during periodic contractions, the oscillations did not disappear. Compared to the contraction phase, the relaxation phase was appreciably inhibited. With only 10(-7) M diltiazem, the rate of inhibition of the contraction phase was 22.0 +/- 7.7%, whereas the preliminary treatment with 5 X 10(-8) M nitroglycerin led to a complete cessation of the oscillations, and suppression of the level of the contractions to a significantly greater extent, viz. 58.7 +/- 5.8% (p less than 0.001). Therefore, it is considered more effective in the treatment and prevention of coronary spasm to use diltiazem and nitroglycerin simultaneously rather than individually.

UI MeSH Term Description Entries
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D010507 Periodicity The tendency of a phenomenon to recur at regular intervals; in biological systems, the recurrence of certain activities (including hormonal, cellular, neural) may be annual, seasonal, monthly, daily, or more frequently (ultradian). Cyclicity,Rhythmicity,Biological Rhythms,Bioperiodicity,Biorhythms,Biological Rhythm,Bioperiodicities,Biorhythm,Cyclicities,Periodicities,Rhythm, Biological,Rhythmicities,Rhythms, Biological
D011460 Prostaglandins F (9 alpha,11 alpha,13E,15S)-9,11,15-Trihydroxyprost-13-en-1-oic acid (PGF(1 alpha)); (5Z,9 alpha,11,alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid (PGF(2 alpha)); (5Z,9 alpha,11 alpha,13E,15S,17Z)-9,11,15-trihydroxyprosta-5,13,17-trien-1-oic acid (PGF(3 alpha)). A family of prostaglandins that includes three of the six naturally occurring prostaglandins. All naturally occurring PGF have an alpha configuration at the 9-carbon position. They stimulate uterine and bronchial smooth muscle and are often used as oxytocics. PGF
D003329 Coronary Vasospasm Spasm of the large- or medium-sized coronary arteries. Coronary Artery Spasm,Coronary Artery Vasospasm,Artery Spasm, Coronary,Artery Vasospasm, Coronary,Coronary Artery Spasms,Coronary Artery Vasospasms,Coronary Vasospasms,Spasm, Coronary Artery,Vasospasm, Coronary,Vasospasm, Coronary Artery
D003331 Coronary Vessels The veins and arteries of the HEART. Coronary Arteries,Sinus Node Artery,Coronary Veins,Arteries, Coronary,Arteries, Sinus Node,Artery, Coronary,Artery, Sinus Node,Coronary Artery,Coronary Vein,Coronary Vessel,Sinus Node Arteries,Vein, Coronary,Veins, Coronary,Vessel, Coronary,Vessels, Coronary
D004110 Diltiazem A benzothiazepine derivative with vasodilating action due to its antagonism of the actions of CALCIUM ion on membrane functions. Aldizem,CRD-401,Cardil,Cardizem,Dilacor,Dilacor XR,Dilren,Diltiazem Hydrochloride,Diltiazem Malate,Dilzem,Tiazac,CRD 401,CRD401
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005996 Nitroglycerin A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives. Glyceryl Trinitrate,Anginine,Dynamite,Gilustenon,Nitrangin,Nitro-Bid,Nitro-Dur,Nitrocard,Nitroderm,Nitroderm TTS,Nitroglyn,Nitrol,Nitrolan,Nitrong,Nitrospan,Nitrostat,Perlinganit,Susadrin,Sustac,Sustak,Sustonit,Transderm Nitro,Tridil,Trinitrin,Trinitrolong,Nitro Bid,Nitro Dur,NitroBid,NitroDur,Trinitrate, Glyceryl
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001552 Benzazepines Compounds with BENZENE fused to AZEPINES.

Related Publications

K Kawasaki, and K Seki, and I Miyazawa, and N Matsumoto, and N Nakanishi, and T Iino, and S Hosoda
May 1989, Circulation,
K Kawasaki, and K Seki, and I Miyazawa, and N Matsumoto, and N Nakanishi, and T Iino, and S Hosoda
December 1990, European journal of pharmacology,
K Kawasaki, and K Seki, and I Miyazawa, and N Matsumoto, and N Nakanishi, and T Iino, and S Hosoda
January 1997, Pulmonary pharmacology & therapeutics,
K Kawasaki, and K Seki, and I Miyazawa, and N Matsumoto, and N Nakanishi, and T Iino, and S Hosoda
May 1986, The American journal of physiology,
K Kawasaki, and K Seki, and I Miyazawa, and N Matsumoto, and N Nakanishi, and T Iino, and S Hosoda
September 1996, Journal of cardiovascular pharmacology,
K Kawasaki, and K Seki, and I Miyazawa, and N Matsumoto, and N Nakanishi, and T Iino, and S Hosoda
May 1991, The American journal of physiology,
K Kawasaki, and K Seki, and I Miyazawa, and N Matsumoto, and N Nakanishi, and T Iino, and S Hosoda
August 1995, Journal of cardiovascular pharmacology,
K Kawasaki, and K Seki, and I Miyazawa, and N Matsumoto, and N Nakanishi, and T Iino, and S Hosoda
June 1988, Japanese journal of pharmacology,
K Kawasaki, and K Seki, and I Miyazawa, and N Matsumoto, and N Nakanishi, and T Iino, and S Hosoda
October 1994, The Journal of pharmacology and experimental therapeutics,
K Kawasaki, and K Seki, and I Miyazawa, and N Matsumoto, and N Nakanishi, and T Iino, and S Hosoda
November 1989, The American journal of cardiology,
Copied contents to your clipboard!